We are live on ! Find out more
VXRT

Vaxart
VXRT

Delisted

VXRT was delisted on the 7th of July, 2025.

Back to rankings

49 hedge funds and large institutions have $18.7M invested in Vaxart in 2016 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 8

5% less capital invested

Capital invested by funds: $19.7M → $18.7M (-$989K)

8% less funds holding

Funds holding: 53 → 49 (-4)

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $4K

Holders
49
Holders Change
-4
Holders Change %
-7.55%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
9
Reduced
8
Closed
9
Calls
–
Puts
$4K
Net Calls
-$4K
Net Calls Change
-$2K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$469K
2
SCM
Stonepine Capital Management
Oregon
+$445K
3
BFA
BlackRock Fund Advisors
California
+$32.8K
4
Renaissance Technologies
Renaissance Technologies
New York
+$26.9K
5
TRCT
Tower Research Capital (TRC)
New York
+$21.7K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$471K
2
BI
BVF Inc
California
-$215K
3
Goldman Sachs
Goldman Sachs
New York
-$53.6K
4
SIM
Spark Investment Management
New York
-$36.7K
5
Morgan Stanley
Morgan Stanley
New York
-$35.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Connor, Clark & Lunn Investment Management (CC&L)
26
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$30K – – –
TRCT
27
Tower Research Capital (TRC)
New York
$28K +$21.7K +1,305 +255%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$27K +$2.76K +166 +11%
Goldman Sachs
29
Goldman Sachs
New York
$21K -$53.6K -3,227 -70%
Morgan Stanley
30
Morgan Stanley
New York
$21K -$35.6K -2,143 -60%
GC
31
Guggenheim Capital
Illinois
$18K – – –
RJFSA
32
Raymond James Financial Services Advisors
Florida
$15K +$15.9K +956 New
BA
33
BlackRock Advisors
Delaware
$13K – – –
JAM
34
JW Asset Management
Florida
$12K – – –
BIM
35
BlackRock Investment Management
Delaware
$9K – – –
CG
36
Cutler Group
California
$9K – – –
Manulife (Manufacturers Life Insurance)
37
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$6K – – –
MA
38
MUFG Americas
New York
$6K – – –
Creative Planning
39
Creative Planning
Kansas
$3K – – –
Group One Trading
40
Group One Trading
Illinois
$3K – – –
NFA
41
Nationwide Fund Advisors
Ohio
$3K – – –
RAM
42
Riggs Asset Management
Pennsylvania
$1K – – –
Bank of America
43
Bank of America
North Carolina
$1K +$17 +1 +2%
BGIM
44
Brandywine Global Investment Management
Pennsylvania
– -$26K -1,545 Closed
Millennium Management
45
Millennium Management
New York
– -$24K -1,477 Closed
Citadel Advisors
46
Citadel Advisors
Florida
– -$20K -1,218 Closed
VKH
47
Virtu KCG Holdings
New York
– -$20K -1,195 Closed
Koshinski Asset Management
48
Koshinski Asset Management
Illinois
– -$19K -1,173 Closed
PAM
49
Panagora Asset Management
Massachusetts
– -$7K -405 Closed
Acadian Asset Management
50
Acadian Asset Management
Massachusetts
– -$6K -373 Closed
1
2
3

VXRT Hedge Fund Activity: Q2 2016 in Review

49 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q2 2016, worth a combined $18.7M — down 5% from $19.7M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of VXRT and 5 opened new positions — a net loss of 4 holders — while 8 trimmed existing stakes and 9 added.

The largest buyer was Vanguard Group, adding an estimated $469K. The largest seller was Fidelity Investments, cutting an estimated $471K.

  • 49 institutional investors held Vaxart (VXRT) as of Q2 2016, down from 53 in Q1 2016.
  • Funds reported $18.7M of Vaxart stock for Q2 2016, down 5% quarter-over-quarter.
  • 5 funds opened new Vaxart positions in Q2 2016 and 9 closed out, a net change of -4 holders.
  • The largest Vaxart buyer in Q2 2016 was Vanguard Group, an estimated $469K added.
  • The largest Vaxart seller in Q2 2016 was Fidelity Investments, an estimated $471K sold.

Based on aggregated 13F filings for Q2 2016.